Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP498855.RAhF8tMRnINgIvFU85Hh-cU6rlXVHw3i4ZGnq1GVVX004130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP498855.RAhF8tMRnINgIvFU85Hh-cU6rlXVHw3i4ZGnq1GVVX004130_assertion type Assertion NP498855.RAhF8tMRnINgIvFU85Hh-cU6rlXVHw3i4ZGnq1GVVX004130_head.
- NP498855.RAhF8tMRnINgIvFU85Hh-cU6rlXVHw3i4ZGnq1GVVX004130_assertion description "[We found that the gene expression level of FHL2 decreased in prostate cancer compared with that of normal tissue and the gene expressions of PSA, AR and SMRT were not significant.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP498855.RAhF8tMRnINgIvFU85Hh-cU6rlXVHw3i4ZGnq1GVVX004130_provenance.
- NP498855.RAhF8tMRnINgIvFU85Hh-cU6rlXVHw3i4ZGnq1GVVX004130_assertion evidence source_evidence_literature NP498855.RAhF8tMRnINgIvFU85Hh-cU6rlXVHw3i4ZGnq1GVVX004130_provenance.
- NP498855.RAhF8tMRnINgIvFU85Hh-cU6rlXVHw3i4ZGnq1GVVX004130_assertion SIO_000772 15948728 NP498855.RAhF8tMRnINgIvFU85Hh-cU6rlXVHw3i4ZGnq1GVVX004130_provenance.
- NP498855.RAhF8tMRnINgIvFU85Hh-cU6rlXVHw3i4ZGnq1GVVX004130_assertion wasDerivedFrom befree-2016 NP498855.RAhF8tMRnINgIvFU85Hh-cU6rlXVHw3i4ZGnq1GVVX004130_provenance.
- NP498855.RAhF8tMRnINgIvFU85Hh-cU6rlXVHw3i4ZGnq1GVVX004130_assertion wasGeneratedBy ECO_0000203 NP498855.RAhF8tMRnINgIvFU85Hh-cU6rlXVHw3i4ZGnq1GVVX004130_provenance.